Executive panel: Building AI-Ready R&D Infrastructure: From Pilot Environments to Enterprise Scientific Compute
Discuss how biopharma organizations are moving beyond fragmented AI pilots to build shared, enterprise-grade compute environments for discovery and development.
Compare the strategic choices between centralized AI platforms, domain-specific scientific environments and federated infrastructure operating models.